David Young - 23 Jun 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
23 Jun 2021
Transactions value $
$76,716
Form type
4
Filing time
23 Jun 2021, 17:12:13 UTC
Previous filing
10 Jun 2021
Next filing
09 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $76,716 +10,000 +2.98% $7.67* 345,190 23 Jun 2021 Direct
holding PCSA Common Stock 548,783 23 Jun 2021 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 689,004 23 Jun 2021 By Family Entities
holding PCSA Common Stock 55,258 23 Jun 2021 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.